Abbott Labs personnel changes
This article was originally published in The Gray Sheet
Executive Summary
Olivier Bouhon appointed senior VP-European operations, Jaime Contreras VP-Latin American diagnostic commercial operations, firm announces June 17. Separately, Abbott reps Jose Rivera, Rick Gonzalez and Rob Gasaway meet with FDA Chief Counsel Daniel Troy June 10 in Rockville, Md. to discuss issues related to company's 1999 consent decree (1"The Gray Sheet" Nov. 8, 1999, p. 4)...
You may also be interested in...
Abbott's AFP, CA 125 Cancer Tests Unaffected By Consent Decree
Abbott Laboratories' AFP and CA 125 diagnostic cancer tests are among the diagnostic products deemed "medically necessary" by FDA and will continue to be made available under the company's Nov. 2 consent decree with the agency.
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Hair Supplement Linked To Cases Of Severe Hepatitis In France
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: